Fu Shiow Yin
Director/Board Member chez FORESEE PHARMACEUTICALS CO., LTD.
Profil
Fu Shiow Yin is an Independent Director at EirGenix, Inc., Foresee Pharmaceuticals Co., Ltd., and a Principal at Yao Hwa Glass Co. Ltd.
Management Committee.
Previously, she worked as a Director at TaiGen Biotechnology Co., Ltd.
and an Independent Director at Pac-Link Bio Venture Capital Investment Corp.
Dr. Yin holds a doctorate degree from the University of Rochester.
Postes actifs de Fu Shiow Yin
| Sociétés | Poste | Début |
|---|---|---|
| FORESEE PHARMACEUTICALS CO., LTD. | Director/Board Member | 31/03/2016 |
| EIRGENIX INC. | Director/Board Member | - |
| Yao Hwa Glass Co. Ltd. Management Committee | Corporate Officer/Principal | - |
Anciens postes connus de Fu Shiow Yin
| Sociétés | Poste | Fin |
|---|---|---|
| Pac-Link Bio Venture Capital Investment Corp. | Independent Dir/Board Member | - |
TaiGen Biotechnology Co., Ltd.
 TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Director/Board Member | - |
Formation de Fu Shiow Yin
| Rochester Christian University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| EIRGENIX INC. | Health Technology |
| FORESEE PHARMACEUTICALS CO., LTD. | Health Technology |
| Entreprise privées | 3 |
|---|---|
| Yao Hwa Glass Co. Ltd. Management Committee | |
TaiGen Biotechnology Co., Ltd.
TaiGen Biotechnology Co., Ltd. Pharmaceuticals: MajorHealth Technology TaiGen Biotechnology Co., Ltd. is a research-based and product-driven pharmaceutical company engaging in the development of therapeutics for infectious diseases, cancer, and diabetes-related complications. Its activities include drug discovery, development, global regulatory, and commercialization in China. The company was founded by Ming-Chu Hsu in 2001 and is headquartered in Taipei, Taiwan. | Health Technology |
| Pac-Link Bio Venture Capital Investment Corp. |
